{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:22:44Z","timestamp":1777566164121,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"the Basic and Applied Research Project of Sichuan Province, China","award":["2013JY0072"],"award-info":[{"award-number":["2013JY0072"]}]},{"name":"the Key Cultivation Project of North Sichuan Medical College, Sichuan Province, China","award":["CBY12-A-ZP06"],"award-info":[{"award-number":["CBY12-A-ZP06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12944-016-0343-z","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T09:40:51Z","timestamp":1475228451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The APOA5 rs662799 polymorphism is associated with dyslipidemia and the severity of coronary heart disease in Chinese women"],"prefix":"10.1186","volume":"15","author":[{"given":"Yanmei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongyan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,30]]},"reference":[{"key":"343_CR1","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jacc.2014.12.044","volume":"65","author":"Y Bi","year":"2015","unstructured":"Bi Y, Jiang Y, He J, Xu Y, Wang L, Xu M, et al. Status of cardiovascular health in Chinese adults. J Am Coll Cardiol. 2015;65:1013\u201325.","journal-title":"J Am Coll Cardiol"},{"key":"343_CR2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case\u2013control study. Lancet. 2004;364:937\u201352.","journal-title":"Lancet"},{"key":"343_CR3","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(83)91849-4","volume":"1","author":"HC Simpson","year":"1983","unstructured":"Simpson HC, Mann JI, Meade TW, Chakrabarti R, Stirling Y, Woolf L. Hypertriglyceridaemia and hypercoagulability. Lancet. 1983;1:786\u201390.","journal-title":"Lancet"},{"key":"343_CR4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/MOL.0000000000000159","volume":"26","author":"LA Lange","year":"2015","unstructured":"Lange LA, Willer CJ, Rich SS. Recent developments in genome and exome-wide analyses of plasma lipids. Curr Opin Lipidol. 2015;26:96\u2013102.","journal-title":"Curr Opin Lipidol"},{"key":"343_CR5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1194\/jlr.P063461","volume":"57","author":"B Gombojav","year":"2016","unstructured":"Gombojav B, Lee SJ, Kho M, Song YM, Lee K, Sung J. Multiple susceptibility loci at chromosome 11q23.3 are associated with plasma triglyceride in East Asians. J Lipid Res. 2016;57:318\u201324.","journal-title":"J Lipid Res"},{"key":"343_CR6","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.2174\/1389450116666150531161138","volume":"16","author":"TM Forte","year":"2015","unstructured":"Forte TM, Ryan RO. Apolipoprotein A5: extracellular and intracellular roles in triglyceride metabolism. Curr Drug Targets. 2015;16:1274\u201380.","journal-title":"Curr Drug Targets"},{"key":"343_CR7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1064852","volume":"294","author":"LA Pennacchio","year":"2001","unstructured":"Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001;294:169\u201373.","journal-title":"Science"},{"key":"343_CR8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.ATV.0000153087.36428.dd","volume":"25","author":"C Priore Oliva","year":"2005","unstructured":"Priore Oliva C, Pisciotta L, Li Volti G, Sambataro MP, Cantafora A, Bellocchio A, et al. Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2005;25:411\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"343_CR9","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1172\/JCI24471","volume":"115","author":"C Mar\u00e7ais","year":"2005","unstructured":"Mar\u00e7ais C, Verges B, Charri\u00e8re S, Pruneta V, Merlin M, Billon S, et al. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J Clin Invest. 2005;115:2862\u20139.","journal-title":"J Clin Invest"},{"key":"343_CR10","doi-asserted-by":"crossref","first-page":"27941","DOI":"10.1074\/jbc.M403240200","volume":"279","author":"FG Schaap","year":"2004","unstructured":"Schaap FG, Rensen PC, Voshol PJ, Vrins C, van der Vliet HN, Chamuleau RA, et al. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem. 2004;279:27941\u20137.","journal-title":"J Biol Chem"},{"key":"343_CR11","doi-asserted-by":"crossref","first-page":"17982","DOI":"10.1074\/jbc.M212191200","volume":"278","author":"N Vu-Dac","year":"2003","unstructured":"Vu-Dac N, Gervois P, Jakel H, Nowak M, Bauge E, Dehondt H, et al. Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators. J Biol Chem. 2003;278:17982\u20135.","journal-title":"J Biol Chem"},{"key":"343_CR12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/2251-6581-13-48","volume":"13","author":"S Halalkhor","year":"2014","unstructured":"Halalkhor S, Jalali F, Tilaki KH, Shojaei S. Association of two common polymorphisms of apolipoprotein A5 gene with metabolic syndrome indicators in a North Iranian population, a cross-sectional study. J Diabetes Metab Disord. 2014;13:48.","journal-title":"J Diabetes Metab Disord"},{"key":"343_CR13","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1194\/jlr.M700285-JLR200","volume":"48","author":"I Sundl","year":"2007","unstructured":"Sundl I, Guardiola M, Khoschsorur G, Sol\u00e0 R, Vallv\u00e9 JC, God\u00e0s G, et al. Increased concentrations of circulating vitamin E in carriers of the apolipoprotein A5 gene - 1131T>C variant and associations with plasma lipids and lipid peroxidation. J Lipid Res. 2007;48:2506\u201313.","journal-title":"J Lipid Res"},{"key":"343_CR14","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1515\/CCLM.2008.161","volume":"46","author":"E Komurcu-Bayrak","year":"2008","unstructured":"Komurcu-Bayrak E, Onat A, Poda M, Humphries SE, Palmen J, Guclu F, et al. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults. Clin Chem Lab Med. 2008;46:778\u201384.","journal-title":"Clin Chem Lab Med"},{"key":"343_CR15","first-page":"598394","volume":"2012","author":"KH Song","year":"2012","unstructured":"Song KH, Yu SG, Cha S, Kim JY. Association of the Apolipoprotein A5 Gene -1131T\u2009>\u2009C Polymorphism with Serum Lipids in Korean Subjects: Impact of Sasang Constitution. Evid Based Complement Alternat Med. 2012;2012:598394.","journal-title":"Evid Based Complement Alternat Med"},{"key":"343_CR16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.atherosclerosis.2005.05.031","volume":"185","author":"LA Hsu","year":"2006","unstructured":"Hsu LA, Ko YL, Chang CJ, Hu CF, Wu S, Teng MS, et al. Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis. 2006;185:143\u20139.","journal-title":"Atherosclerosis"},{"key":"343_CR17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1399-0004.2004.00251.x","volume":"65","author":"GP Li","year":"2004","unstructured":"Li GP, Wang JY, Yan SK, Chen BS, Xue H, Wu G. Genetic effect of two polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene on serum lipids and lipoproteins levels in a Chinese population. Clin Genet. 2004;65:470\u20136.","journal-title":"Clin Genet"},{"key":"343_CR18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ygeno.2007.08.001","volume":"90","author":"Y Yamada","year":"2007","unstructured":"Yamada Y, Matsuo H, Warita S, Watanabe S, Kato K, Oguri M, et al. Prediction of genetic risk for dyslipidemia. Genomics. 2007;90:551\u20138.","journal-title":"Genomics"},{"key":"343_CR19","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1194\/jlr.M200480-JLR200","volume":"44","author":"BE Aouizerat","year":"2003","unstructured":"Aouizerat BE, Kulkarni M, Heilbron D, Drown D, Raskin S, Pullinger CR, et al. Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids. J Lipid Res. 2003;44:1167\u201373.","journal-title":"J Lipid Res"},{"key":"343_CR20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2008.04.013","volume":"394","author":"S Charriere","year":"2008","unstructured":"Charriere S, Bernard S, Aqallal M, Merlin M, Billon S, Perrot L, et al. Association of APOA5 -1131T\u2009>\u2009C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients. Clin Chim Acta. 2008;394:99\u2013103.","journal-title":"Clin Chim Acta"},{"key":"343_CR21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.atherosclerosis.2004.04.024","volume":"176","author":"KW Lee","year":"2004","unstructured":"Lee KW, Ayyobi AF, Frohlich JJ, Hill JS. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease. Atherosclerosis. 2004;176:165\u201372.","journal-title":"Atherosclerosis"},{"key":"343_CR22","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.metabol.2004.11.009","volume":"54","author":"H Liu","year":"2005","unstructured":"Liu H, Zhang S, Lin J, Li H, Huang A, Xiao C, et al. Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism. 2005;54:568\u201372.","journal-title":"Metabolism"},{"key":"343_CR23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2003.12.003","volume":"173","author":"C Szalai","year":"2004","unstructured":"Szalai C, Keszei M, Duba J, Proh\u00e1szka Z, Kozma GT, Cs\u00e1sz\u00e1r A, et al. Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis. 2004;173:109\u201314.","journal-title":"Atherosclerosis"},{"key":"343_CR24","doi-asserted-by":"crossref","first-page":"e46385","DOI":"10.1371\/journal.pone.0046385","volume":"7","author":"F Takeuchi","year":"2012","unstructured":"Takeuchi F, Isono M, Katsuya T, Yokota M, Yamamoto K, Nabika T, et al. Association of genetic variants influencing lipid levels with coronary artery disease in Japanese individuals. PLoS One. 2012;7:e46385.","journal-title":"PLoS One"},{"key":"343_CR25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.atherosclerosis.2006.04.009","volume":"191","author":"N Martinelli","year":"2007","unstructured":"Martinelli N, Trabetti E, Bassi A, Girelli D, Friso S, Pizzolo F, et al. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study. Atherosclerosis. 2007;191:409\u201317.","journal-title":"Atherosclerosis"},{"key":"343_CR26","doi-asserted-by":"crossref","first-page":"e0135683","DOI":"10.1371\/journal.pone.0135683","volume":"10","author":"H Ye","year":"2015","unstructured":"Ye H, Zhou A, Hong Q, Tang L, Xu X, Xin Y, et al. Positive Association between APOA5 rs662799 Polymorphism and Coronary Heart Disease: A Case\u2013control Study and Meta-Analysis. PLoS One. 2015;10:e0135683.","journal-title":"PLoS One"},{"key":"343_CR27","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.7754\/Clin.Lab.2015.150331","volume":"61","author":"B Shen","year":"2015","unstructured":"Shen B, Zhao W, Zheng Y, Chen X, Xu W, Li S. An Association Study Identifies Two Single Nucleotide Polymorphisms on Chromosome 11q23.3 as a Risk Locus for Acute Myocardial Infarction in the Chinese Han Population. Clin Lab. 2015;61:1609\u201316.","journal-title":"Clin Lab"},{"key":"343_CR28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4162\/nrp.2015.9.4.379","volume":"9","author":"M Yamasaki","year":"2015","unstructured":"Yamasaki M, Mutombo PB, Iwamoto M, Nogi A, Hashimoto M, Nabika T, et al. The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese. Nutr Res Pract. 2015;9:379\u201384.","journal-title":"Nutr Res Pract"},{"key":"343_CR29","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3892\/mmr.2013.1642","volume":"8","author":"J Zhou","year":"2013","unstructured":"Zhou J, Xu L, Huang RS, Huang Y, Le Y, Jiang D, et al. Apolipoprotein A5 gene variants and the risk of coronary heart disease: a case\u2013control study and meta-analysis. Mol Med Rep. 2013;8:1175\u201382.","journal-title":"Mol Med Rep"},{"key":"343_CR30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1745-6215-15-100","volume":"15","author":"R Kang","year":"2014","unstructured":"Kang R, Kim M, Chae JS, Lee SH, Lee JH. Consumption of whole grains and legumes modulates the genetic effect of the APOA5 -1131C variant on changes in triglyceride and apolipoprotein A-V concentrations in patients with impaired fasting glucose or newly diagnosed type 2 diabetes. Trials. 2014;15:100.","journal-title":"Trials"},{"key":"343_CR31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cca.2008.12.024","volume":"402","author":"Y Jang","year":"2009","unstructured":"Jang Y, Paik JK, Hyun YJ, Chae JS, Kim JY, Choi JR, et al. The apolipoprotein A5\u20131131T\u2009>\u2009C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease. Clin Chim Acta. 2009;402:83\u20137.","journal-title":"Clin Chim Acta"},{"key":"343_CR32","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National Cholesterol Education Program (NCEP)","year":"2002","unstructured":"National Cholesterol Education Program (NCEP). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143\u2013421.","journal-title":"Circulation"},{"key":"343_CR33","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","volume":"51","author":"GG Gensini","year":"1983","unstructured":"Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51:606.","journal-title":"Am J Cardiol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-016-0343-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T00:50:11Z","timestamp":1568422211000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-016-0343-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,30]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["343"],"URL":"https:\/\/doi.org\/10.1186\/s12944-016-0343-z","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,30]]},"article-number":"170"}}